Skip to main content
. 2017 Nov 8;256(1):59–69. doi: 10.1007/s00417-017-3831-6

Fig. 1.

Fig. 1

Patient flow through the study (mITT population). AE adverse event, DEX dexamethasone intravitreal implant, mITT modified intent-to-treat